Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Lactoferrin for Prevention of Sepsis in Preterm Neonates
NCT07480434Phase 1Completed
- Sponsor
- Zartash Sial Paeds Med
- Start
- Oct 2024
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of bovine lactoferrin in sepsis (2 arms), sponsored by Zartash Sial Paeds Med. Primary endpoint: Incidence of Neonatal Sepsis at 7 days. Started Oct 2024; status: completed.
02
Drugs
bovine lactoferrin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07480434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07480434.